Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure

Kidney International

Volumn 55, Issue 5, 1999, Pages 1899-1911

  Stenvinkel, Peter ^a,b,c   Heimbürger, Olof ^a,b,c   Paultre, Furcy ^a,b,c   Diczfalusy, Ulf ^a,b,c   Wang, Tao ^a,b,c   Berglund, Lars ^a,b,c   Jogestrand, Tomas ^a,b,c  

^a KAROLINSKA INSTITUTE   (Sweden)

^b Columbia University ^*  (United States)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Apo(a) isoforms; Atherosclerosis; Cardiovascular disease; Inflammation; Nutrition; Oxidative stress; Uremia

Indexed keywords

ACUTE PHASE PROTEIN; APOLIPOPROTEIN A1; C REACTIVE PROTEIN;

ADULT; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; B SCAN; CARDIOVASCULAR DISEASE; CAROTID ARTERY; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; DYSLIPIDEMIA; FEMALE; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; MALNUTRITION; MORTALITY; NUTRITIONAL STATUS; OXIDATIVE STRESS; PRIORITY JOURNAL; RISK FACTOR; UREMIA;

EID: 0032952901     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.1999.00422.x     Document Type: Article

References (59)

1. 1. LINDNER A, CHARRA B, SHERRARD DJ, SCHRIBNER BH: Accelerated atherosclerosis in prolonged maintenance haemodialysis. N Engl J Med 290:697-701, 1974
2. 2. MA KW, GREENE EL, RAIJ L: Cardiovascular risk factors in chronic renal failure and hemodialysis populations. Am J Kidney Dis 19:505-513, 1992
3. 3. LAMEIRE N, BERNAERT P, LAMBERT M-C, VIJT D: Cardiovascular risk factors and their management in patients on continuous ambulatory peritoneal dialysis. Kidney Int 46(Suppl 48):S31-S38, 1994
4. 4. RAINE AEG, MARGREITER R, BRUNNER FP, EHRICH JHH, GEELINGS W, LANDAIS P, LOIRAT C, MALLICK NP, SELWOOD NH, TUFVESSON G, VALDERRABANO F: Report on the management of renal failure in Europe, XXII. Nephrol Dial Transplant Suppl 2:7-35, 1992
5. 5. CRESSMAN MD, HEYKA RJ, PAGANINI EP, O'NEIL J, SKIBINSKI CI, HOFF HF: Lipoprotein(a) is an independent risk factor for cardiovascular disease in hemodialysis patients. Circulation 86:475-482, 1992
6. 6. KOCH M, KUTKUHN B, GRABENSEE B, RITZ E: Apolipoprotein A, fibrinogen, age, and a history of stroke are predictors of death in dialyzed diabetic patients: A prospective study in 412 subjects. Nephrol Dial Transplant 12:2603-2611, 1997
7. 7. KRONENBERG F, KATHREIN H, KÖNIG P, NEYER U, STURM W, LHOTTA K, GRÖCHENIG E, UTERMAN G, DIEPLINGER H: Apolipoprotein(a) phenotypes predict the risk for carotid atherosclerosis in patients with end-stage renal disease. Arterioscler Thromb 14:1405-1411, 1994
8. 8. KRONENBERG F, TRENKWALDER E, STURM W, KATHREIN H, KÖNIG P, NEYER U, GRÖCHENIG E, UTERMAN G, DIEPLINGER H: LDL-unbound apolipoprotein(a) and carotid atherosclerosis in hemodialysis patients. Clin Genet 52:377-386, 1997
9. 9. KOCH M, KUTKUHN B, TRENKWALDER E, BACK D, GRABENSEE B, DIEPLINGER H, KRONENBERG F: Apolipoprotein B, fibrinogen, HDL cholesterol and apolipoprotein (a) phenotypes predict coronary heart disease in hemodialysis patients. J Am Soc Nephrol 8:1889-1898, 1997
10. 10. BERGSTRÖM J, LINDHOLM B: Nutrition and adequacy of dialysis: How do hemodialysis and CAPD compare? Kidney Int 34(Suppl):S39-S50, 1993
11. 11. KEANE WF, COLLINS AJ: Influence of co-morbidity on mortality and morbidity of hemodialysis patients. Am J Kidney Dis 24:1010-1018, 1994
12. 12. LOWRIE EG, LEW NL: Death risk in hemodialysis patients: The predicative value of commonly measured variables and an evaluation of death rate differences between facilities. Am J Kidney Dis 15:458-482, 1990
13. 13. QURESHI AR, ALVESTRAND A, DANIELSSON A, DIVINO-FILHO JC, GUTIERREZ A, LINDHOLM B, BERGSTRÖM J: Factors influencing malnutrition in hemodialysis patients: A cross-sectional study. Kidney Int 53:773-782, 1998
14. 14. KAYSEN GA, STEVENSON FT, DEPNER TA: Determinants of albumin concentration in hemodialysis patients. Am J Kidney Dis 29:658-668, 1997
15. 15. STENVINKEL P, HEIMBÜRGER O, TUCK C, BERGLUND L: Apo(a) isoform size, nutritional status and inflammatory markers in chronic renal failure. Kidney Int 53:1336-1342, 1998
16. 16. RIDKER PM, CUSHMAN M, STAMPFER MJ, RUSSELL PT, HENNEKENS CH: Inflammation, aspirin and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 336:973-979, 1997
17. 17. NIETO FJ, ADAM E, SORLIE P, FARZADEGAN H, MELNICK JL, COMSTOCK GW, SZKLO M: Cohort study of cytomegalovirus infection as a risk factor for carotid intimal-medial thickening, a measure of subclinical atherosclerosis. Circulation 94:922-927, 1996
18. 18. MATTILA LJ, NIEMINEN MS, VALTONEN VV, RASI VP, KESANIEMI YA, SYRJALA SL, JUNGELL PS, ISOLUOMA M, HIETANIEMI K, JOKINEN MJ: Association between dental health and acute myocardial infarction. BMJ 298:779-781, 1989
19. 19. PASCERI V, CAMMAROTA G, PATTI G, CUOCO L, GASBARRINI A, GRILLO RL, FEDELI G, GASBARRINO G, MASERI A: Association of virulent helicobacter pylori strains with ischemic heart disease. Circulation 97:1675-1679, 1998
20. 20. JOUSILAHTI P, VARTIANIEN E, TUOMILEHTO J, PUSKA P: Symptoms of chronic bronchitis and the risk of coronary disease. Lancet 348:567-572, 1996
21. 21. HALLIWELL B: The role of oxygen radicals in human disease with particular reference to the vascular system. Haemostasis 23(Suppl 1):118-126, 1993
22. 22. STENVINKEL P, HOLMBERG I, HEIMBÜRGER O, DICZFALUSY U: A study of plasmalogen as an index of oxidative stress in patients with chronic renal failure: Evidence of increased oxidative stress in malnourished patients. Nephrol Dial Transplant 13:2594-2600, 1998
23. 23. BOOSALIS MG, SNOWDON DA, TULLY CL, GROSS MD: Acute phase response and plasma carotenoid concentrations in older women: Findings from the nun study. Nutrition 12:475-478, 1996
24. 24. HUANG YH, RÖNNELID J, FROSTEGÅRD J: Oxidized LDL induces enhanced antibody formation and MCH class II-dependent INF-gamma production in lymphocytes from healthy individuals. Arterioscler Thromb Vasc Biol 15:1577-1583, 1995
25. 25. JOVINGE S, ARES MP, KALLIN B, NILSSON J: Human monocytes/macrophages release TNF-α in response to oxidized LDL. Arterioscler Thromb Vasc Biol 16:1573-1579, 1996
26. 26. LOPES-VIRELIA MF, STONE P, ELNIS S, COLWEH JA: Cholesterol determination in high-density lipoproteins separated by three different methods. Clin Chem 23:882-884, 1977
27. 27. FRIEDEWALD WT, LEVY RI, FREDRICKSON DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem 18:499-502, 1977
28. 28. KAMBOH MI, FERRELL RE, KOTTKE BA: Expressed hypervariable polymorphism of apolipoprotein(a). Am J Hum Genet 49:1063-1074, 1991
29. 29. CATIGNANI GL, BIERI JG: Simultaneous determination of retinol and alpha-tocopherol in serum or plasma by liquid chromatography. Clin Chem 29:708-712, 1983
30. 30. BAKER JP, DETSKY AS, WESSON DE, WOLMAN SL, STEWART S, WHITEWELL J, LANGER B, JEEJEEBHOY KN: A comparison of clinical judgment and objective measurements. N Engl J Med 306:969-972, 1982
31. 31. DETSKY AS, MCLAUGHLIN JR, BAKER JP, JOHNSTON N, WHITTAKER S, MENDELSON RA, JEEJEEBHOY KN: What is subjective global assessment of nutritional status? J Parenter Enterol Nutr 11:8-13, 1987
32. 32. JOGESTRAND T, NOWAK J, SYLVÉN C: Improvement of common carotid intima-media complex measurements by calculating the cross-sectional area. J Vasc Invest 4:193-195, 1995
33. 33. LEMNE C, JOGESTRAND T, DEFAIRE U: Carotid intima-media thickness and plaque in borderline hypertension. Stroke 26:34-39, 1995
34. 34. NOWAK J, NILSSON T, SYLVÉN C, JOGESTRAND T: Potential of carotid ultrasonography in the diagnosis of coronary artery disease: A comparison with exercise test and variance ECG. Stroke 29:439-446,1998
35. 35. KAWAGISHI T, NISHIZAWA Y, KONISHI T, KAWASAKI K, EMOTO M, SHOJI T, TABATA T, INOUE T, MORII H: High-resolution ultrasonography in evaluation of atherosclerosis in uremia. Kidney Int 48:820-826, 1995
36. 36. SAVAGE T, CLARKE AL, GILES M, TOMSON CRV, RAINE AEG: Calcified plaque is common in the carotid and femoral arteries of dialysis patients without clinical vascular disease. Nephrol Dial Transplant 13:2004-2012, 1998
37. 37. SALONEN JT, SALONEN R: Ultrasonographically assessed carotid morphology and the risk of coronary heart disease. Arterioscler Thromb 11:1245-1249, 1991
38. 38. MITCHELL JRA, SCHWARTZ JC: Relationship between arterial disease in different sites: A study of the aorta and coronary, carotid and iliac arteries. BMJ 5288:1293-1301, 1962
39. 39. HODIS HN, MACK WJ, LABREE L, SELZER RH, LIU C, LIU C, AZEN SP: The role of carotid arterial intima-media thickness in predicting clinical coronary events. Ann Intern Med 128:262-269, 1998
40. 40. ACCHIARDO SR, MOORE LW, LATOUR PA: Malnutrition as a main factor in morbidity and mortality of hemodialysis patients. Kidney Int 24(Suppl 16):S199-S203, 1983
41. 41. BERGSTRÖM J, LINDHOLM B: Malnutrition, cardiac disease, and mortality: An integrated point of view. Am J Kidney Dis 32:834-841, 1998
42. 42. KOPPLE JD: Nutritional management of nondialyzed patients with chronic renal failure, in Nutritional Management of Renal Disease, edited by KOPPLE JD, MASSRY SG, Baltimore, William & Wilkins, 1996, pp 479-531
43. 43. BARTENS W, NAUCK M, SCHOLLMEYER P, WANNER C: Elevated lipoprotein (a) and fibrinogen levels increase the cardiovascular risk in continuous ambulatory peritoneal dialysis patients. Perit Dial Int 16:27-33, 1996
44. 44. FOLSOM AR, MA J, ECKFELDT JH, NIETO FJ, METCALFE PA, BARNES RW: Low serum albumin: Association with diabetes mellitus and other cardiovascular risk factors but not with prevalent cardiovascular disease or carotid artery intima-media thickness. Ann Epidemiol 5:186-191, 1995
45. 45. ZIMMERMANN J, HERRLINGER S, PRUY A, METZGER T, WANNER C: Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int 55:648-658, 1999
46. 46. DANESH J, COLLINS R, PETO R: Chronic infections and coronary heart disease: Is there a link? Lancet 350:430-436, 1997
47. 47. PEREIRA BJG, SHAPIRO L, KING AJ, FALAGAS ME, STROM JA, DINARELLO CA: Plasma levels of IL-1β, TNF-α and their specific inhibitors in undialyzed chronic renal failure, CAPD and hemodialysis patients. Kidney Int 45:890-896, 1994
48. 48. ELNEIHOUM AM, FALKE P, HEDBLAD B, LINDGÄRDE F, OHLSSON K: Leukocyte activation in atherosclerosis: Correlation with risk factors. Atherosclerosis 131:79-84, 1997
49. 49. SALONEN JT, YLÄ-HERTTULA S, YAMAMOTO R, BUTLER S, KORPELA H, SALONEN R, NYYSSÖNEN K, PALINSKI W, WITZTUM JL: Autoantibody against oxidised LDL and progression of carotid atherosclerosis. Lancet 339:883-887, 1992
50. 50. REGNSTRÖM J, NILSSON J, TORNVALL P, LANDAU C, HAMSTEN A: Susceptibility to low-density lipoprotein oxidation and coronary atherosclerosis in man. Lancet 339:1183-1186, 1992
51. 51. ANDO M, LUNDQVIST I, BERGSTRÖM J, LINDHOLM B: Enhanced scavenger receptor expression in monocyte-macrophages on dialysis patients. Kidney Int 49:773-780, 1996
52. 52. DIEBER-ROTHENEDER M, PUHL H, WAEG G, STRIEGL G, ESTERBAUER H: Effect of oral supplementation with D-α-tocopherol on the vitamin E content of human low density lipoproteins and the resistance to oxidation. J Lipid Res 32:1325-1332, 1991
53. 53. LONDON GM, DRÜEKE TB: Atherosclerosis and arteriosclerosis in chronic renal failure. Kidney Int 51:1678-1695, 1997
54. 54. MASSY ZA, KASISKE BL: Hyperlipidemia and its management in renal disease. Curr Opin Nephrol Hypertens 5:141-146, 1996
55. 55. CASTELLI WP, GARRISON RJ, WILSON WF, ABBOTT RD, KALOUSDIAN S, KANNEL WB: Incidence of coronary heart disease and lipoprotein cholesterol levels: The Framingham study. JAMA 256:2835-2838, 1986
56. 56. MARTIN MJ, HULLEY SB, BROWNER WS, KULLER LH, WENTHWORTH D: Serum cholesterol, blood pressure, and mortality: Implications from a cohort of 361,662 men. Lancet 2:933-936, 1986
57. 57. JUNGERS P, MASSY ZA, KHOA TN, FUMERON C, LABRUNIE N, LACOUR B, DESCAMPS-LATSCHA B, MAN NK: Incidence and risk factors for atherosclerotic cardiovascular accidents in predialysis chronic renal failure. Nephrol Dial Transplant 12:2597-2602, 1997
58. 58. AVRAM MM, GOLDWASSER P, BURRELL DE, ANTIGNANI A, FEIN PA, MITTMAN N: The uremic dyslipidemia: A cross-sectional and longitudinal study. Am J Kidney Dis 10:324-335, 1992
59. 59. SANDHOLZER C, SAHA N, KARK JD, REES A, JAROSS W, DIEPLINGER H, HOPPLICHER F, BOERWINKLE E, UTERMAN G: Apo(a) isoforms predict risk for coronary heart disease: A study in six populations. Arterioscler Thromb 12:1214-1226, 1992